• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPV-16 感染与宫颈癌:感染持续时间和癌前病变影响的建模。

HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions.

机构信息

Department of Infectious Disease Epidemiology, St Mary's Campus, Imperial College, London W2 1PG, UK.

出版信息

Epidemics. 2010 Mar;2(1):21-8. doi: 10.1016/j.epidem.2010.02.002. Epub 2010 Feb 10.

DOI:10.1016/j.epidem.2010.02.002
PMID:21352773
Abstract

The patterns of transmission, clearance, and progression of HPV infection and the related precancerous lesions are key to accurately model cervical cancer epidemiology and prevention. We have developed an age-structured dynamic model of the transmission of HPV-16 infection. This mathematical model accounts, for the first time, for the effect of infection and precancerous lesions duration on the natural history of HPV-16 infection and precancerous lesions. The model's output has been fitted to contemporaneous sets of data from Turin, Italy, to estimate parameters that have had been indirectly tested by comparing them with other estimates reported in the literature. The average probability of HPV-16 infection transmission per sexual partnership was about 40%. The HPV-16 clearance and progression rates decreased as the length of time with infection increased, clearance ranging between 1.6 per woman-year (in the first 6 months of infection) and 0.036 (after more than 6 years of infection), and progression between 0.072 and 0.018 per woman-year. The rate of clearance of precancerous lesions (CIN2+) was inversely dependent on age, while the progression of CIN2+ toward invasive cervical cancer increased as the precancerous lesions persisted. The present study also suggests that an exclusive role of women's age in shaping the rate of progression to cancer is unlikely. These results should inform future analyses. Including more accurately the role of the duration of infection and precancerous lesions as determinants of the cervical cancer occurrence in models of cervical cancer control may influence predictors of the effectiveness of intervention strategies.

摘要

HPV 感染及其相关癌前病变的传播、清除和进展模式是准确模拟宫颈癌流行病学和预防的关键。我们开发了一种 HPV-16 感染传播的年龄结构动态模型。该数学模型首次考虑了感染和癌前病变持续时间对 HPV-16 感染和癌前病变自然史的影响。该模型的输出结果已与意大利都灵的同期数据集相拟合,以估计参数,这些参数是通过与文献中报告的其他估计值进行比较间接测试的。每个性伴侣 HPV-16 感染的平均传播概率约为 40%。HPV-16 的清除率和进展率随着感染时间的延长而降低,清除率在女性-年 1.6(感染的前 6 个月)至 0.036(感染 6 年以上)之间,进展率在女性-年 0.072 至 0.018 之间。癌前病变(CIN2+)的清除率与年龄呈负相关,而 CIN2+向浸润性宫颈癌的进展则随着癌前病变的持续而增加。本研究还表明,癌症进展率仅由女性年龄决定的可能性不大。这些结果应该为未来的分析提供信息。在宫颈癌控制模型中,更准确地纳入感染和癌前病变持续时间作为宫颈癌发生的决定因素的作用,可能会影响干预策略有效性的预测因素。

相似文献

1
HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions.HPV-16 感染与宫颈癌:感染持续时间和癌前病变影响的建模。
Epidemics. 2010 Mar;2(1):21-8. doi: 10.1016/j.epidem.2010.02.002. Epub 2010 Feb 10.
2
Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.中国对轻度细胞学异常女性进行人乳头瘤病毒基因分型以预测宫颈高级别鳞状上皮内病变或癌风险的研究
Acta Cytol. 2015;59(5):405-11. doi: 10.1159/000441290. Epub 2015 Nov 14.
3
Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions.多种人乳头瘤病毒(HPV)基因型引起的宫颈感染:患病率及其对癌前上皮病变风险的影响。
J Med Virol. 2009 Apr;81(4):703-12. doi: 10.1002/jmv.21429.
4
HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.在中国西南部,HPV-16、HPV-58 和 HPV-33 是致癌性最强的 HPV 基因型,其病毒载量与宫颈前病变的严重程度相关。
Virol J. 2018 May 25;15(1):94. doi: 10.1186/s12985-018-1003-x.
5
Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.预测宫颈上皮内瘤变 2 级保守治疗的因素:细胞学和 HPV 基因分型。
Gynecol Oncol. 2021 Sep;162(3):569-574. doi: 10.1016/j.ygyno.2021.06.019. Epub 2021 Jul 2.
6
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
7
Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.挪威宫颈癌前病变发病率的近期增加:1992 年至 2016 年的全国性研究。
Int J Cancer. 2019 Nov 15;145(10):2629-2638. doi: 10.1002/ijc.32195. Epub 2019 Mar 4.
8
[Risk of cervical cancer and precancerous diseases in the oral HPV carriers].口腔人乳头瘤病毒携带者患宫颈癌及癌前疾病的风险
Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):611-6.
9
Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.人乳头瘤病毒(HPV)基因分型和多重感染在宫颈癌前病变和癌症的早期检测及 HPV 疫苗接种中的作用
BMC Cancer. 2022 Jan 6;22(1):42. doi: 10.1186/s12885-021-09126-3.
10
Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.委内瑞拉浸润性宫颈癌及宫颈上皮内瘤变 2 级和 3 级中人类乳头瘤病毒的分布情况:一项横断面研究。
Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

引用本文的文献

1
The Creation of the Suppressive Cancer Microenvironment in Patients with HPV-Positive Cervical Cancer.人乳头瘤病毒阳性宫颈癌患者中抑制性癌症微环境的形成
Diagnostics (Basel). 2022 Aug 6;12(8):1906. doi: 10.3390/diagnostics12081906.
2
Association between interleukin-2, interleukin-10, secretory immunoglobulin A and immunoglobulin G expression in vaginal fluid and human papilloma virus outcome in patients with cervical lesions.宫颈病变患者阴道液中白细胞介素-2、白细胞介素-10、分泌型免疫球蛋白A和免疫球蛋白G表达与人类乳头瘤病毒转归的关系。
Oncol Lett. 2019 Nov;18(5):5543-5548. doi: 10.3892/ol.2019.10897. Epub 2019 Sep 20.
3
Nine challenges for deterministic epidemic models.
确定性流行病模型面临的九个挑战。
Epidemics. 2015 Mar;10:49-53. doi: 10.1016/j.epidem.2014.09.006. Epub 2014 Sep 27.
4
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.获得性免疫在人乳头瘤病毒(HPV)传播中的作用:基于微观模拟模型的探究
PLoS One. 2015 Feb 2;10(2):e0116618. doi: 10.1371/journal.pone.0116618. eCollection 2015.
5
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.用于对HPV阳性女性进行分流的知情细胞学检查:嵌套于NTCC随机对照试验中的子研究
J Natl Cancer Inst. 2015 Jan 7;107(2). doi: 10.1093/jnci/dju423. Print 2015 Feb.
6
The impact of HPV female immunization in Italy: model based predictions.人乳头瘤病毒(HPV)女性免疫接种在意大利的影响:基于模型的预测
PLoS One. 2014 Mar 11;9(3):e91698. doi: 10.1371/journal.pone.0091698. eCollection 2014.
7
Type-specific human papillomavirus biological features: validated model-based estimates.特定类型人乳头瘤病毒的生物学特征:基于验证模型的估计
PLoS One. 2013 Nov 29;8(11):e81171. doi: 10.1371/journal.pone.0081171. eCollection 2013.
8
Infection transmission and chronic disease models in the study of infection-associated cancers.感染相关癌症研究中的感染传播和慢性疾病模型。
Br J Cancer. 2014 Jan 7;110(1):7-11. doi: 10.1038/bjc.2013.740. Epub 2013 Dec 3.
9
In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa.芒柄花黄素对人宫颈癌HeLa细胞系的体外和体内抗癌活性
Tumour Biol. 2014 Mar;35(3):2279-84. doi: 10.1007/s13277-013-1302-1. Epub 2013 Nov 24.
10
Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.疫苗接种对 14 种高危 HPV 型感染的影响:一种数学建模方法。
PLoS One. 2013 Aug 29;8(8):e72088. doi: 10.1371/journal.pone.0072088. eCollection 2013.